News Conference News The Structural Heart Disease Summit 2018 PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial Shelley Wood June 23, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
News Daily News Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions L.A. McKeown June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018
News Daily News NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests Todd Neale June 21, 2018
News Daily News ‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers Yael L. Maxwell June 20, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018